FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00
- £139.15m
- £144.40m
RCS - Faron Pharma. Oy - MATINS Trial in Cell Reports Medicine
AnnouncementREG - Faron Pharma. Oy - Grant of options
AnnouncementREG - Faron Pharma. Oy - Faron Initiates Phase 2 Part of BEXMAB Study
AnnouncementRCS - Faron Pharma. Oy - Faron to present data from BEXMAB study at ASH
AnnouncementREG - AIM - AIM Notice - 30/10/2023
AnnouncementREG - Faron Pharma. Oy - Manager's transactions
AnnouncementREG - Faron Pharma. Oy - Results of Placing
AnnouncementREG - Faron Pharma. Oy - Exercise of options
AnnouncementREG - Faron Pharma. Oy - Proposed Issue and Placing
AnnouncementREG - Faron Pharma. Oy - Faron Announces Positive BEXMAB Study Update
AnnouncementRCS - Faron Pharma. Oy - Faron to host webcast on new BEXMAB study data
AnnouncementREG - Faron Pharma. Oy - Board Changes
AnnouncementREG - Faron Pharma. Oy - Results of EGM
AnnouncementREG - Faron Pharma. Oy - Faron Appoints Interim Chief Medical Officer
AnnouncementREG - AIM - AIM Notice - 11/09/2023
AnnouncementREG - Faron Pharma. Oy - Change in the Board of Directors
AnnouncementRCS - Faron Pharma. Oy - Faron to Present at H.C. Wainwright Conference
AnnouncementREG - Faron Pharma. Oy - Notice of EGM
AnnouncementREG - Faron Pharma. Oy - Exercise of options
Announcement